Oncology PulsePoint: How NCCN Breast Cancer Updates Are Changing Testing and Treatment
Oncology PulsePoint: How NCCN Breast Cancer Updates Are Changing Testing and Treatment Pharmacy Times
Онкология
🎗️Лента новостей
Онкология
PanCAN Marks Pancreatic Cancer Awareness Month with New Hope as Breakthroughs in Treatments Signal a New Era for Patients
PanCAN Marks Pancreatic Cancer Awareness Month with New Hope as Breakthroughs in Treatments Signal a New Era for Patients Pancreatic Cancer Action Network
Онкология
Turning Cancer Research Into Action Through Storytelling and Strategic Communication - NCI Center for Global Health
Turning Cancer Research Into Action Through Storytelling and Strategic Communication - NCI Center for Global Health Oncodaily
🎗️
Онкология
Durvalumab Plus Enfortumab Vedotin Improves Survival in Bladder Cancer
Durvalumab Plus Enfortumab Vedotin Improves Survival in Bladder Cancer Oncology News Central
Онкология
Arsenic drug combo resurrects 'guardian of the genome' to fight aggressive blood cancers
A combination cancer therapy that relies on the reactivation of a tumor suppressor protein to kill leukemic and other blood cancer cells has shown promise in a small pilot trial.
Онкология
China’s innovative anti-cancer drugs highlighted at global oncology event
China’s innovative anti-cancer drugs highlighted at global oncology event Global Times
🎗️
Онкология
Genmab Shares Hit Record as Cancer Trial Extends Drugmaker’s Run
Genmab Shares Hit Record as Cancer Trial Extends Drugmaker’s Run Bloomberg.com
Онкология
Wei Zhang: Hanes and Willis Family Professorship Fuels Innovation in Cancer Research
Wei Zhang: Hanes and Willis Family Professorship Fuels Innovation in Cancer Research Oncodaily
Онкология
How the tumor environment influences bowel cancer cells' behavior and chemotherapy response
New research led by experts at the University of Nottingham has revealed how collagen in the tumor environment can alter bowel cancer cell behavior and influence inflammatory responses to chemotherapy, highlighting potential new avenues for future research into cancer treatment. The findings, published in the Journal…
Онкология
Вакцина против меланомы снизила риск рецидива и смерти на 42%: результаты испытаний удивили ученых
Вакцина против меланомы снизила риск рецидива и смерти на 42%: результаты испытаний удивили ученых bigmir)net
Онкология
Ученые обнаружили маркеры рака в анализах за 10 лет до болезни
Ученые обнаружили маркеры рака в анализах за 10 лет до болезни Национальная Служба Новостей
Онкология
Двойной удар по опухоли: российские учёные испытали соединения против устойчивого рака лёгкого
Двойной удар по опухоли: российские учёные испытали соединения против устойчивого рака лёгкого Правда.Ру
Онкология
Maria Hafez: Is Innovation Enough Without Equal Access to Cancer Treatment?
Maria Hafez: Is Innovation Enough Without Equal Access to Cancer Treatment? Oncodaily
Онкология
Cell-level analysis reveals how ovarian tumors may develop resistance to chemotherapy
High-grade serous ovarian cancer is an aggressive form of ovarian cancer, characterized in particular by high diversity among the cells that compose a given tumor. This intratumor heterogeneity is a major challenge in understanding why some tumors respond to treatments and others resist. Additionally, this diversity…